CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 93 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,697,075 | -15.7% | 290,595 | -3.3% | 0.01% | -23.1% |
| Q3 2022 | $2,012,000 | +59.1% | 300,358 | 0.0% | 0.01% | +62.5% |
| Q2 2022 | $1,265,000 | +12.4% | 300,358 | -10.0% | 0.01% | +33.3% |
| Q1 2022 | $1,125,000 | +6.6% | 333,758 | -0.4% | 0.01% | +20.0% |
| Q4 2021 | $1,055,000 | -5.0% | 335,045 | -1.4% | 0.01% | -16.7% |
| Q3 2021 | $1,111,000 | -22.8% | 339,837 | -0.4% | 0.01% | -14.3% |
| Q2 2021 | $1,440,000 | -15.4% | 341,343 | 0.0% | 0.01% | -22.2% |
| Q1 2021 | $1,703,000 | -60.5% | 341,343 | -0.0% | 0.01% | -64.0% |
| Q4 2020 | $4,316,000 | +27.7% | 341,455 | -0.8% | 0.02% | +13.6% |
| Q3 2020 | $3,379,000 | -3.5% | 344,051 | -2.3% | 0.02% | -12.0% |
| Q2 2020 | $3,503,000 | +8.7% | 352,020 | -3.4% | 0.02% | -13.8% |
| Q1 2020 | $3,223,000 | -6.4% | 364,544 | -2.3% | 0.03% | +20.8% |
| Q4 2019 | $3,442,000 | +56.9% | 373,119 | 0.0% | 0.02% | +60.0% |
| Q3 2019 | $2,194,000 | -52.4% | 373,119 | -3.0% | 0.02% | -50.0% |
| Q2 2019 | $4,614,000 | -4.8% | 384,469 | -4.2% | 0.03% | -6.2% |
| Q1 2019 | $4,846,000 | -8.4% | 401,529 | -4.7% | 0.03% | -11.1% |
| Q4 2018 | $5,289,000 | -21.9% | 421,410 | -7.7% | 0.04% | -5.3% |
| Q3 2018 | $6,776,000 | -2.5% | 456,634 | +10.5% | 0.04% | -2.6% |
| Q2 2018 | $6,953,000 | -8.1% | 413,122 | +25.1% | 0.04% | -15.2% |
| Q1 2018 | $7,562,000 | +193.7% | 330,200 | +231.8% | 0.05% | +206.7% |
| Q4 2017 | $2,575,000 | +540.5% | 99,525 | +369.5% | 0.02% | +400.0% |
| Q4 2015 | $402,000 | -32.4% | 21,200 | -33.1% | 0.00% | -40.0% |
| Q3 2015 | $595,000 | +48.4% | 31,700 | +17.8% | 0.01% | +25.0% |
| Q2 2015 | $401,000 | +5.8% | 26,900 | +7.6% | 0.00% | +33.3% |
| Q1 2015 | $379,000 | +110.6% | 25,000 | +85.2% | 0.00% | +200.0% |
| Q4 2014 | $180,000 | – | 13,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |